In today’s analysis we discover an American cloud-computing company focused on pharmaceutical and life sciences industry applications.
The main key data of the company are the following:
- Revenues of $ 1.5 billion in constant growth and estimated to increase further by 30%
- High business margins with a 25% profit margin
- Earnings forecast up 30%
Key data to know
The company covered by this analysis is represented by a BullDude’s Card, which is a single image that contains all the key data you need to know, from more general information to key business data from recent years and expectations of future growth.
In particular, the focus is on: the ability to increase the size of the business (by increasing Revenue) and ability to produce a net profit at the end of the year after all costs incurred (positive and growing Net Income).
Furthermore, the focus is on the ability to improve business efficiency, increasing the main business margins, especially what concerns the operational part that is not affected by financial and fiscal costs (positive and growing EBITDA margin).
*Data in Millions of USD
1-Year Stock Price Chart
Are you a member? Login